Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
August 11, 2025
Global Competition Review – Americas Antitrust Review 2026
Axinn managing partner Jeny Maier, counsel Monica Smith, and associate Leandra Ipiña co-authored a chapter in Global Competition Review’s Americas Antitrust Review 2026 titled “Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector.”
Click here to access the chapter.
Accreditation: This article was first published on Global Competition Review in August 2025; for further in-depth analysis, please visit GCR - Americas Antitrust Review 2026
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust
29th Annual IBA Competition Conference
Sponsorship
Antitrust
Key Appellate Decisions Shaping Antitrust Strategy
Webinar
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
MCCA Pathways Conference
Sponsorship
Antitrust
HNBA/VIA Annual Convention 2025
Sponsorship
Antitrust